ISDS Case Map
GMOs
An issue that has received less attention is the implications of the FTA for the entry of genetically modified organisms (GMO's) into Peru.
Bilateral and unilateral, initiatives are the new avatars of globalisation and free trade. And it is these avatars we must challenge to stop corporate rule, while WTO hangs between intensive care and the crematorium.
Agreement between the US, Canada, and Mexico with respect to the documentation requirements of the Cartagena Protocol on Biosafety pertaining to living modified organisms intended for direct use as food or feed or for processing (LMO/FFPs), signed in October 2004.
South Korea and the US have agreed to establish a standing committee on sanitary standards for agricultural and food products, which will make it easier for the US to ask for expanded trade of genetically modified crops. However, negotiations on pharmaceuticals have hit a snag, with neither side willing to budge.
Letter from the US Biotechnology Industry Organisation to the US Trade Representative on intellectual property, GM labelling, biosafety, GM contamination and other issues BIO wants addressed under the US-Korea FTA talks.
Letter from the US Biotechnology Industry Organisation to the US Trade Representative on intellectual property, GM labelling, biosafety, GM contamination and other issues BIO wants addressed under the US-Malaysia FTA talks.
Bilateral free trade agreements are seen by the agricultural biotechnology industry as an
important conduit for spreading genetically modified organisms (GMOs) around the world.
Report of the US government's Industry Trade Advisory Committee on Intellectual Property Rights (ITAC-15)
The Cartagena Protocol on Biosafety "is alive," although there were complaints about and criticism of modifications to the final agreement reached at the Third Meeting of the Parties to the Protocol (MOP3). The aim of the compromise that Mexico successfully pressed for is to not hinder the country's free trade agreements with other countries.
The Biotechnology Industry Organization (BIO) today applauded the Bush Administration's announcement to begin free trade negotiations with Malaysia. "Malaysia is an important market with a strong interest in developing its biotechnology industry," stated Jim Greenwood, President and CEO of BIO. "We look forward to working with US Trade Representative Rob Portman on this important initiative as Malaysia looks to enhance the development of its biotechnology sector.
